Literature DB >> 24071517

Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways.

Feng Zhang1, Zili Zhang1, Desong Kong1, Xiaoping Zhang1, Li Chen1, Xiaojing Zhu1, Yin Lu2, Shizhong Zheng3.   

Abstract

Hepatic stellate cell (HSC) activation is the central event during liver fibrogenesis. Metabolic syndrome characterized by hyperglycemia and hyperinsulinemia contributes to nonalcoholic steatohepatitis-associated liver fibrosis. This study was to investigate the effects of tetramethylpyrazine (TMP) on HSC activation induced by glucose and insulin (Glu/Ins) and the underlying mechanisms. Results showed that Glu/Ins significantly stimulated proliferation, invasion, adhesion, and extracellular matrix (ECM) production in HSCs. TMP inhibited HSC proliferation, invasion and adhesion, and reduced the expression of marker genes related to HSC activation in Glu/Ins-activated HSCs. Mechanistic evidence revealed that TMP reduced insulin receptor (InsR) expression and blocked the downstream phosphatidylinositol-3-kinase (PI3K)/AKT and extracellular signal-regulated kinase (ERK) cascades, which was required for TMP attenuation of HSC activation. Moreover, TMP modulated the genes relevant to ECM homeostasis favoring ECM degradation. It could be concluded that TMP inhibited Glu/Ins-stimulated HSC activation and ECM production by inhibiting InsR-mediated PI3K/AKT and ERK pathways.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-phenyl)-2H-tetrazolium; BSA; CTGF; DMEM; Dulbecco’s modified eagle medium; ECM; ERK; Extracellular matrix; FBS; GAPDH; Glu/Ins; HSC; Hepatic stellate cell; InsR; Insulin receptor; JNK; Liver fibrosis; MAPK; MMP; MTS; NAFLD; NASH; PBS; PI3K; T2DM; TIMP; TMP; Tetramethylpyrazine; bovine serum albumin; c-Jun N-terminal kinase; connective tissue growth factor; extracellular matrix; extracellular signal-regulated kinase; fetal bovine serum; glucose and insulin; glyceraldehyde phosphate dehydrogenase; hepatic stellate cell; insulin receptor; matrix metalloproteinase; mitogen-activated protein kinase; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; phosphate buffered saline; phosphatidylinositol-3-kinase; tetramethylpyrazine; tissue inhibitor of metalloproteinase; type II diabetes mellitus; α-SMA; α-smooth muscle actin

Mesh:

Substances:

Year:  2013        PMID: 24071517     DOI: 10.1016/j.mce.2013.09.020

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  19 in total

1.  Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Cindy X Cai; Hema Buddha; Shobha Castelino-Prabhu; Zhiwei Zhang; Robert S Britton; Bruce R Bacon; Brent A Neuschwander-Tetri
Journal:  Dig Dis Sci       Date:  2017-02-13       Impact factor: 3.199

2.  CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease.

Authors:  Denitra A Breuer; Maria Cristina Pacheco; M Kay Washington; Stephanie A Montgomery; Alyssa H Hasty; Arion J Kennedy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-11       Impact factor: 4.052

3.  Canonical hedgehog signalling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis.

Authors:  Feng Zhang; Meng Hao; Huanhuan Jin; Zhen Yao; Naqi Lian; Li Wu; Jiangjuan Shao; Anping Chen; Shizhong Zheng
Journal:  Br J Pharmacol       Date:  2017-01-31       Impact factor: 8.739

4.  Hepatic kinome atlas: An in-depth identification of kinase pathways in liver fibrosis of humans and rodents.

Authors:  Justin F Creeden; Zachary A Kipp; Mei Xu; Robert M Flight; Hunter N B Moseley; Genesee J Martinez; Wang-Hsin Lee; Khaled Alganem; Ali S Imami; Megan R McMullen; Sanjoy Roychowdhury; Atta M Nawabi; Jennifer A Hipp; Samir Softic; Steven A Weinman; Robert McCullumsmith; Laura E Nagy; Terry D Hinds
Journal:  Hepatology       Date:  2022-04-08       Impact factor: 17.298

5.  Yi-Qi-Jian-Pi Formula Suppresses RIPK1/RIPK3-Complex-Dependent Necroptosis of Hepatocytes Through ROS Signaling and Attenuates Liver Injury in Vivo and in Vitro.

Authors:  Feixia Wang; Li Tang; Baoyu Liang; Chun Jin; Liyuan Gao; Yujia Li; Zhanghao Li; Jiangjuan Shao; Zili Zhang; Shanzhong Tan; Feng Zhang; Shizhong Zheng
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

6.  Tetramethylpyrazine inhibits CTGF and Smad2/3 expression and proliferation of hepatic stellate cells.

Authors:  Jun Li; Ni Dong; Shuang Cheng; Xiaosheng Li; Wenli Wang; Ying Xiang
Journal:  Biotechnol Biotechnol Equip       Date:  2015-01-28       Impact factor: 1.632

7.  Effects of Tetramethylpyrazine on Functional Recovery and Neuronal Dendritic Plasticity after Experimental Stroke.

Authors:  Jun-Bin Lin; Chan-Juan Zheng; Xuan Zhang; Juan Chen; Wei-Jing Liao; Qi Wan
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-26       Impact factor: 2.629

8.  Tetramethylpyrazine Inhibits Activation of Hepatic Stellate Cells through Hedgehog Signaling Pathways In Vitro.

Authors:  Jue Hu; Gang Cao; Xin Wu; Hao Cai; Baochang Cai
Journal:  Biomed Res Int       Date:  2015-08-24       Impact factor: 3.411

Review 9.  Mechanisms and Clinical Application of Tetramethylpyrazine (an Interesting Natural Compound Isolated from Ligusticum Wallichii): Current Status and Perspective.

Authors:  Yingke Zhao; Yue Liu; Keji Chen
Journal:  Oxid Med Cell Longev       Date:  2016-09-07       Impact factor: 6.543

10.  Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α.

Authors:  Feng Zhang; Shuai Lu; Jianlin He; Huanhuan Jin; Feixia Wang; Li Wu; Jiangjuan Shao; Anping Chen; Shizhong Zheng
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.